Whole person health and the role of RWE: An interview with Dr Kavita Lamror, Partner, RWE & Digital Transformation, Maxis Clinical Sciences

Written by The Evidence Base
Health data Interviews ISPOR Medical devices, pharmaceuticals and vaccines Real-world evidence

Laura Dormer, Editor of The Evidence Base, speaks with Dr Kavita Lamror, Partner, RWE & Digital Transformation, Maxis Clinical Sciences about whole person health and the role of RWE.

You can view the entire video or view a specific question by entering ‘Fullscreen with Transcript’ or navigate via the ‘Visual Table of Contents’.

Questions:

  • 0:00: Please could you introduce yourself and tell us a little about your background?
  • 1:15: You joined Maxis Clinical Sciences last year to spearhead RWE and digital transformation initiatives. What projects/strategies have been the most important priorities for you in taking on this role?
  • 3:19: How would you define whole person health?
  • 4:46: What role does RWE play in helping deliver a vision of whole person health?
  • 7:15: What are some of the challenges of utilizing RWD in an HEOR/HTA setting?
  • 9:28: How does Maxis Clinical Sciences work with partners to integrate RWD/E into clinical research? Are there any recent case examples you can share?
  • 11:21: How do you hope the use of RWE and delivering on the mission of Whole Person Health will evolve over the next 5–10 years, and what is needed to achieve this?

 

Dr Kavita Lamror
Partner, RWE & Digital Transformation, Maxis Clinical Sciences

Dr Kavita Lamror, a key figure at Maxis Clinical Sciences, spearheads Real-World Evidence and Digital Transformation initiatives. Holding an MPH from Johns Hopkins Bloomberg School of Public Health, her diverse career spans academia, pharma, and medical devices. At Maxis, she leverages her data analytics prowess and evidence-based approach to elevate patient health outcomes. Before her tenure at Maxis, Dr Lamror directed global RWE studies for cardiovascular and central nervous system products at leading pharmaceutical companies. Her visionary leadership has been instrumental in the development of custom RWE products and in transforming Value Evidence functions into revenue-generating verticals.

Sponsorship for this interview was provided by Maxis Clinical Sciences.